All News
Tyk2 Inhibition Effective in SLE
Deucravacitinib, an oral, selective TYK2 inhibitor, has demonstrated efficacy in a phase II trial active systemic lupus erythematosus (SLE) patients.
Read Article
How Underweight Women Can Reduce Hip Fracture Risk
d
EurekAlert!
How women can reduce the risk of hip fracture?
Read Article
Cancer Screening Recommendations in Idiopathic Inflammatory Myopathy
Idiopathic inflammatory myopathy (IIM) is associated with increased risk of lung, ovarian, colorectal, lymphoma, breast, and naso-pharyngeal cancers, often within three years of disease onset. At ACR22, plenary abstract 0002, Oldroyd, et al, reviewed the 18 recommendations provided by the International Myositis Assessment and Clinical Studies Group (IMACS) steering committee.
Read Article
Prescribing Methotrexate in Post-Roe Era
Dr. Cassy Sims ( @DrCassySims) reports live from #ACR22.
L09: Impact on Access to Methotrexate in the Post-Roe Era
https://t.co/GwgSqBj5EX https://t.co/WzFGnJyIf3
Links:
Dr. John Cush RheumNow ( View Tweet)
Is exercise the missing medicine in lupus?
Sarah Patterson, MD from UCSF will present oral abstract #2225 entitled “Physical Inactivity is Associated with Increased Expression of T cell inflammatory genes in Systemic Lupus.”
https://t.co/LomZ8U8pzj https://t.co/PEZHypeasB
Links:
Dr. John Cush RheumNow ( View Tweet)
To Switch or Not: Biosimilars in Inflammatory Arthritis
Dr. Jonathan Kay reports on abstract 1112 at #ACR22 Convergence.
https://t.co/nrsH7yB7wu https://t.co/TngS4Kk6YK
Links:
Dr. John Cush RheumNow ( View Tweet)
Artificial Intelligence in Detecting Sacroiliitis
Dr. Akhil Sood ( @AkhilSoodMD) discusses Abstract 0383 at #ACR22.
https://t.co/U52eAFOePr https://t.co/8WcecoF5Sr
Links:
Dr. John Cush RheumNow ( View Tweet)
Retrospective study looked at 47 adults w/ dermatomyositis treated with tofacitinib. While clinically similar, those on TOFA were were younger (53vs 61), shorter Rx duration (24 vs 53 mos);there was signif CDASI improvement. #ACR22 https://t.co/HrC1GLZQRR https://t.co/yiHsxhpiWe
Links:
Dr. John Cush RheumNow ( View Tweet)
TIME Mag - "Why Masks Still Matter". 1) COVID is still out there; 2) Influenza on the rise. Authors write "With limited yet mixed data, we would be wise to ...err on the side of masking in high risk, indoor crowded public settings..." https://t.co/l8jiTwAdZz https://t.co/0QUKJDOhjs
Links:
Dr. John Cush RheumNow ( View Tweet)
1st quarter of 2022, only 29% of Medicaid and Medicare users had at least one telehealth visit - down from 46% in all of 2021. (Data from Centers for Medicare & Medicaid Services) https://t.co/RCYjlJOPS3
Dr. John Cush RheumNow ( View Tweet)
Will a vegetarian diet and exercise actually help RA disease activity?
At #ACR22, a Dutch program targeting a whole food plant-based diet, physical activity, and stress management has shown benefit in DAS28 RA disease activity measures.
https://t.co/W2axkmbs3y https://t.co/5jktGiEk0T
Links:
Dr. John Cush RheumNow ( View Tweet)
Open label trial compared arthroscopic repair to PT in 100 young pts w/ traumatic, MRI proven meniscal tear without knee OA. Outcomes at 24 months - both groups improvved and were not different between groups https://t.co/rbrUAWuKRa https://t.co/OaNTssAvCG
Links:
Dr. John Cush RheumNow ( View Tweet)
Medication adherence is a problem
I assume that when I prescribe something for patients that they fill the prescription (right away) and take it as planned…or is this a pipe dream?
@Janetbirdope weighs in.
https://t.co/qj3insA6fL https://t.co/yV0xlvdNZu
Links:
Dr. John Cush RheumNow ( View Tweet)
Does Evusheld shield people living with rheumatic diseases?
Dr. Yuz Yusof ( @Yuz6Yusof) discusses three key abstracts from #ACR22 on Evusheld findings.
https://t.co/wYl6Wpd5Fs https://t.co/7T7u4czNOX
Links:
Dr. John Cush RheumNow ( View Tweet)
A look back at #ACR22 Day 1.
https://t.co/UIZnquWAiU https://t.co/EZ2su56J5H
Links:
Dr. John Cush RheumNow ( View Tweet)
FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/6pMwBPFJJr https://t.co/lTdpX0FQwj
Links:
Dr. John Cush RheumNow ( View Tweet)
Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/vcvW8N11cm https://t.co/N5zx0I0lrn
Links:
Dr. John Cush RheumNow ( View Tweet)
Where are we with treating Pre-Rheumatoid Arthritis?
Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0530, #1603 and #1604 shared at #ACR22.
https://t.co/AagsZCyhSE https://t.co/K1RvdOMzvf
Links:
Dr. John Cush RheumNow ( View Tweet)
Spondyloarthritis Topic Panel - #ACR22
SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims
@synovialjoints @AkhilSoodMD @ericdeinmd @RHEUMarampa @DrCassySims
https://t.co/uFPW3NxZEm https://t.co/stjmhcFoaS
Links:
Dr. John Cush RheumNow ( View Tweet)
Women vs. Men: Response to Treatment in Seronegative Arthritis
Dr. Janet Pope ( @Janetbirdope) discusses abstracts 1614 and 1601 at #ACR22
https://t.co/nUFjPr1Zya https://t.co/L47pzS7YXv
Links:
Dr. John Cush RheumNow ( View Tweet)